125 related articles for article (PubMed ID: 8092887)
1. Preoperative and postoperative CA-125 serum levels in primary fallopian tube carcinoma.
Rosen AC; Klein M; Rosen HR; Graf AH; Lahousen M; Reiner A; Vavra N; Auerbach L
Arch Gynecol Obstet; 1994; 255(2):65-8. PubMed ID: 8092887
[TBL] [Abstract][Full Text] [Related]
2. Preoperative diagnosis of primary fallopian tube carcinoma by transvaginal ultrasound, cytological finding and CA-125.
Podobnik M; Singer Z; Ciglar S; Bulic M
Ultrasound Med Biol; 1993; 19(7):587-91. PubMed ID: 8310554
[TBL] [Abstract][Full Text] [Related]
3. Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.
Luyckx M; Leblanc E; Filleron T; Morice P; Darai E; Classe JM; Ferron G; Stoeckle E; Pomel C; Vinet B; Chereau E; Bergzoll C; Querleu D
Int J Gynecol Cancer; 2012 Oct; 22(8):1337-43. PubMed ID: 22964527
[TBL] [Abstract][Full Text] [Related]
4. The clinical, serological, pathological and immunocytochemical features of a case of primary carcinoma of the fallopian tube.
Gadducci A; Madrigali A; Ciancia EM; Campani D; Facchino V; Fioretti P
Eur J Gynaecol Oncol; 1993; 14(5):374-9. PubMed ID: 8253096
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining for CA-125 in fallopian tube carcinomas.
Puls LE; Davey DD; DePriest PD; Gallion HH; van Nagell JR; Hunter JE; Pavlik EJ
Gynecol Oncol; 1993 Mar; 48(3):360-3. PubMed ID: 8462903
[TBL] [Abstract][Full Text] [Related]
6. Raised serum CA 125 preceding the diagnosis of carcinoma of the fallopian tube: two case reports.
Davies AP; Fish A; Woolas R; Oram D
Br J Obstet Gynaecol; 1991 Jun; 98(6):602-3. PubMed ID: 1873255
[No Abstract] [Full Text] [Related]
7. Levels of CA 125 in patients with recurrent carcinoma of the fallopian tube: two case histories.
Lootsma-Miklosova E; Aalders JG; Willemse PH; de Bruijn HW
Eur J Obstet Gynecol Reprod Biol; 1987 Mar; 24(3):231-5. PubMed ID: 3470229
[TBL] [Abstract][Full Text] [Related]
8. Primary Mucinous Carcinoma of the Fallopian Tube: Case Report and Review of Literature.
Wheal A; Jenkins R; Mikami Y; Das N; Hirschowitz L
Int J Gynecol Pathol; 2017 Jul; 36(4):393-399. PubMed ID: 27662036
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
10. Management and prognosis of primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma.
Rosen AC; Klein M; Hafner E; Lahousen M; Graf AH; Reiner A
Gynecol Obstet Invest; 1999; 47(1):45-51. PubMed ID: 10026026
[TBL] [Abstract][Full Text] [Related]
11. Carcinoma of the fallopian tube.
Baekelandt M; Jorunn Nesbakken A; Kristensen GB; Tropé CG; Abeler VM
Cancer; 2000 Nov; 89(10):2076-84. PubMed ID: 11066048
[TBL] [Abstract][Full Text] [Related]
12. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
Rosendahl M; Høgdall CK; Mosgaard BJ
Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated antigen CA 195 in patients with mucinous ovarian tumours: a comparative analysis with CEA, TATI and CA 125 in serum specimens and cyst fluids.
de Bruijn HW; ten Hoor KA; Boonstra H; Marrink J; Krans M; Aalders JG
Tumour Biol; 1993; 14(2):105-15. PubMed ID: 8392219
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 72 patients.
Wolfson AH; Tralins KS; Greven KM; Kim RY; Corn BW; Kuettel MR; Philippart C; Raub WA; Randall ME
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):71-6. PubMed ID: 9422560
[TBL] [Abstract][Full Text] [Related]
15. A single-institution evaluation of factors important in fallopian tube carcinoma recurrence and survival.
Shamshirsaz AA; Buekers T; Degeest K; Bender D; Zamba G; Goodheart MJ
Int J Gynecol Cancer; 2011 Oct; 21(7):1232-40. PubMed ID: 21720254
[TBL] [Abstract][Full Text] [Related]
16. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study.
Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G
Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic value of serum human epididymis protein 4 in patients with primary fallopian tube carcinoma.
Mi D; Zhang YX; Wang CJ; Feng Q; Qi P; Chen SQ
J Obstet Gynaecol Res; 2016 Oct; 42(10):1326-1335. PubMed ID: 27307153
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies.
Yogi T; Hijioka S; Imaoka H; Mizuno N; Hara K; Tajika M; Tanaka T; Ishihara M; Shimizu Y; Hosoda W; Yatabe Y; Niwa Y; Yoshimura K; Bhatia V; Fujita J; Yamao K
J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):757-65. PubMed ID: 26148131
[TBL] [Abstract][Full Text] [Related]
19. [Primary fallopian tube cancer].
Böhme M; Donat H; Baumann D
Zentralbl Gynakol; 1992; 114(5):244-8. PubMed ID: 1320802
[TBL] [Abstract][Full Text] [Related]
20. Preoperative diagnosis of fallopian tube carcinoma by transvaginal sonography and CA-125.
Kol S; Gal D; Friedman M; Paldi E
Gynecol Oncol; 1990 Apr; 37(1):129-31. PubMed ID: 2182403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
